Analysts’ Viewpoint on Taurine Market Scenario
Global supply chains are set for a major overhaul as the COVID-19 crisis has exposed the vulnerability of countries and companies that rely heavily on limited number of trading partners. Many brands use taurine as a complement to various other stimulants in their beverage formula. However, these beverages are under scrutiny for using synthetic taurine that can potentially harm the health of individuals. Hence, companies in the taurine market should diversify their production activities in food and pharmaceutical grade taurine, which is considered relatively safe for consumption in products. Moreover, taurine-based technology is playing a key role in innovations for hair products.
The high prevalence of taurine deficiency in cats and dogs is fueling the demand for nutritious pet food innovations. Celebrity endorsements for pet food products in India through eCommerce and traditional media are translating into value-grab opportunities for brands in the taurine market.
Taurine is being publicized as an essential amino acid, which helps to maintain healthy heart and improves eyesight of cats and dogs. Brands in the taurine market are capitalizing on this opportunity to bolster their output capacities, as omega 3 & 6 fatty acids keep the coat beautiful and lustrous. The blend of organic minerals, along with taurine and other ingredients helps to control urinary pH. Thus, pet food manufacturers are increasing the production of prebiotics and probiotics to protect cats from hairball formation and keep their digestive system healthy.
Manufacturers in the taurine market are increasing local production capabilities to reduce dependence on other countries for raw materials and other products during the ongoing COVID-19 crisis. They are maintaining optimum inventory levels to ensure business continuity and robust supply chains.
Companies in the taurine market are focusing on mission-critical applications such as increasing availability of healthcare products and pet food and beverages (F&B) among health- and pet-conscious consumers. Market stakeholders are establishing a balanced relationship with suppliers and ecosystem partners to keep the economies running. They are unlocking potentials in eCommerce for increasing the uptake of healthcare products, pet food, and beverage items. Participants in the market are drawing an analysis to understand their high-risk clients and customers where recovery of debt may be an issue.
Energy drinks are generating revenue opportunities for manufacturers in the taurine market. Taurine is gaining popularity as an essential amino acid, which is naturally found in animal-based foods such as meat and dairy. These foods help to support neurological development among individuals. Even though it is safe for consumption in food, there is a lack of evidence about the effects of taurine during pregnancy in supplement form and when combined with energy drinks. Hence, manufacturers are diversifying production activities in healthcare and pet food to generate new income sources.
Manufacturers are increasing the production of pharmaceutical and food grade taurine to expand revenue streams in healthcare and pet food products.
Apart from food products, manufacturers in the taurine market are tapping revenue opportunities in cleaning products, cosmetics, and flavors, among other applications. Companies are presenting Certified Reference Material (CRM) for food and pharmaceutical grade taurine, which is in accordance with ISO (International Organization for Standardization) standards. Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost effective alternative to pharmacopoeia primary standards.
Secondary standards for pharmaceutical applications are suitable for use in several analytical applications, including, but not limited to, pharma release testing, F&B quality control testing, and pharma method development for qualitative and quantitative analyses. Such findings are contributing to the growth of the taurine market.
Brands are making use of taurine in hair products to meet demanding needs of women. In order to achieve this, companies are investing in R&D to advance in taurine-based technology that can be used to create wavy effects even with very straight hair, thus offering results that last for over a month. Innovative hair products are helping women to achieve natural movement in the hair, without affecting the quality of the fiber, whilst enhancing consumer experience such as smell & setting time.
An increasing number of women are opting for modern salon services to unlock creativity in hairstyles whilst taking care of the hair fiber. Such trends are creating revenue opportunities for taurine manufacturers.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 0.2 Bn |
|
Market Forecast Value in 2031 |
US$ 0.3 Bn |
|
Growth Rate (CAGR) |
5.3 % |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Additionally, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, supply chain analysis, and parent industry overview. |
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global taurine market was worth US$ 0.2 Bn and is projected to reach a value of US$ 0.3 Bn by the end of 2031
Taurine market is anticipated to grow at a CAGR of 5.3% during the forecast period
North America accounted for a major share of the global taurine market
Taurine market is driven by the rise in demand for taurine-based medicine & food and lifting of ban on taurine by few prominent countries
Key players in the global taurine market include Taisho Pharmaceutical Holdings Co., Ltd., Grand Pharmaceutical Group Limited, AWI-Awell Ingredients Co., Ltd., The Honjo Chemical Corporation, Qianjiang Yongan Pharmaceutical Co., Ltd., A. B. Enterprises, Atlantic Chemicals Trading GmbH, Kyowa Hakko Bio Co., Ltd., Jiangsu Yuanyang Pharmaceutical Co., Ltd., Hubei Grand Fuchi Pharmaceutical & Chemicals Co., Ltd., Advance Inorganics, Aakriti Trading Company, and Avanscure LifeSciences Pvt. Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Taurine Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Taurine Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Qualitative Information of different applications, forms & types of taurine in Global market
5.2. Overview of Clinical Trials Data on Taurine
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemic Impact on Industry (value chain and / mid / long term impact)
6. Global Taurine Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Food Grade
6.3.2. Pharmaceutical Grade
6.4. Market Attractiveness Analysis, by Type
7. Global Taurine Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Health Care Products
7.3.2. Pet Food
7.3.3. Beverage
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Taurine Market Analysis and Forecast, by Form
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Form, 2017–2031
8.3.1. Tablets/Capsules
8.3.2. Liquid-based Serum
8.3.3. Others
8.4. Market Attractiveness Analysis, by Form
9. Global Taurine Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Taurine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2031
10.2.1. Food Grade
10.2.2. Pharmaceutical Grade
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Health Care Products
10.3.2. Pet Food
10.3.3. Beverage
10.3.4. Others
10.4. Market Value Forecast, by Form, 2017–2031
10.4.1. Tablets/Capsules
10.4.2. Liquid-based Serum
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By Form
10.6.4. By Country
11. Europe Taurine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. Food Grade
11.2.2. Pharmaceutical Grade
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Health Care Products
11.3.2. Pet Food
11.3.3. Beverage
11.3.4. Others
11.4. Market Value Forecast, by Form, 2017–2031
11.4.1. Tablets/Capsules
11.4.2. Liquid-based Serum
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By Form
11.6.4. By Country/Sub-region
12. Asia Pacific Taurine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Food Grade
12.2.2. Pharmaceutical Grade
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Health Care Products
12.3.2. Pet Food
12.3.3. Beverage
12.3.4. Others
12.4. Market Value Forecast, by Form, 2017–2031
12.4.1. Tablets/Capsules
12.4.2. Liquid-based Serum
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By Form
12.6.4. By Country/Sub-region
13. Latin America Taurine Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Food Grade
13.2.2. Pharmaceutical Grade
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Health Care Products
13.3.2. Pet Food
13.3.3. Beverage
13.3.4. Others
13.4. Market Value Forecast, by Form, 2017–2031
13.4.1. Tablets/Capsules
13.4.2. Liquid-based Serum
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By Form
13.6.4. By Country/Sub-region
14. Middle East & Africa Taurine Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Food Grade
14.2.2. Pharmaceutical Grade
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Health Care Products
14.3.2. Pet Food
14.3.3. Beverage
14.3.4. Others
14.4. Market Value Forecast, by Form, 2017–2031
14.4.1. Tablets/Capsules
14.4.2. Liquid-based Serum
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By Form
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Taisho Pharmaceutical Holdings Co., Ltd.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. Grand Pharmaceutical Group Limited
15.4.2.1. Company Description
15.4.2.2. Business Overview
15.4.2.3. Financial Overview
15.4.2.4. SWOT Analysis
15.4.3. AWI-Awell Ingredients Co., Ltd.
15.4.3.1. Company Description
15.4.3.2. SWOT Analysis
15.4.4. The Honjo Chemical Corporation
15.4.4.1. Company Description
15.4.4.2. SWOT Analysis
15.4.5. Qianjiang Yongan Pharmaceutical Co., Ltd.
15.4.5.1. Company Description
15.4.5.2. Business Overview
15.4.5.3. SWOT Analysis
15.4.6. A. B. Enterprises
15.4.6.1. Company Description
15.4.6.2. SWOT Analysis
15.4.7. Atlantic Chemicals Trading GmbH
15.4.7.1. Company Description
15.4.7.2. SWOT Analysis
15.4.8. Kyowa Hakko Bio Co., Ltd.
15.4.8.1. Company Description
15.4.8.2. SWOT Analysis
15.4.9. Jiangsu Yuanyang Pharmaceutical Co., Ltd.
15.4.9.1. Company Description
15.4.9.2. SWOT Analysis
15.4.10. Hubei Grand Fuchi Pharmaceutical & Chemicals Co., Ltd.
15.4.10.1. Company Description
15.4.10.2. SWOT Analysis
15.4.11. Advance Inorganics
15.4.11.1. Company Description
15.4.11.2. SWOT Analysis
15.4.12. Aakriti Trading Company
15.4.12.1. Company Description
15.4.12.2. SWOT Analysis
15.4.13. Avanscure Lifesciences Pvt. Ltd.
15.4.13.1. Company Description
15.4.13.2. SWOT Analysis
List of Tables
Table 01: Global Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 03: Global Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 04: Global Taurine Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Taurine Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 07: North America Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 08: North America Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 09: Europe Taurine Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 11: Europe Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 12: Europe Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 13: Asia Pacific Taurine Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 15: Asia Pacific Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 16: Asia Pacific Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 17: Latin America Taurine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 19: Latin America Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 20: Latin America Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
Table 21: Middle East & Africa Taurine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Taurine Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 23: Middle East & Africa Taurine Market Value Share and Attractiveness Analysis, by Application, 2017–2031
Table 24: Middle East & Africa Taurine Market Value Share and Attractiveness Analysis, by Form, 2017–2031
List of Figures
Figure 01: Market Share, by Type
Figure 02: Market Share, by Application
Figure 03: Market Share, by Form
Figure 04: Global Taurine Market Value (US$ Mn) Forecast, 2017–2031
Figure 05: Global Taurine Market Value Share, by Type, 2020
Figure 06: Global Taurine Market Value Share, by Application, 2020
Figure 07: Global Taurine Market Value Share, by Form, 2020
Figure 08: Global Taurine Market Value Share, by Region, 2020
Figure 09: Pipeline Analysis
Figure 10: Confirmed Total Cases in Different Countries, 2020
Figure 11: Cumulative Total Confirmed & Death Cases Across Countries, 2020
Figure 12: Total Recovered Cases Across Countries, 2020
Figure 13: Global Taurine Market, by Type
Figure 14: Global Taurine Market Value Share Analysis, by Type, 2020 and 2031
Figure 15: Global Taurine Market Attractiveness Analysis, by Type, 2021–2031
Figure 16: Global Taurine Market Revenue (US$ Mn), by Food Grade, 2017–2031
Figure 17: Global Taurine Market Revenue (US$ Mn), by Pharmaceutical Grade, 2017–2031
Figure 18: Global Taurine Market, by Application
Figure 19: Global Taurine Market Value Share and Attractiveness Analysis, by Application, 2020 and 2031
Figure 20: Global Taurine Market Value Share and Attractiveness Analysis, by Application, 2021–2031
Figure 21: Global Taurine Market Revenue (US$ Mn), by Health Care Products, 2017–2031
Figure 22: Global Taurine Market Revenue (US$ Mn), by Pet Food, 2017–2031
Figure 23: Global Taurine Market Revenue (US$ Mn), by Beverage, 2017–2031
Figure 24: Global Taurine Market Revenue (US$ Mn), by Others, 2017–2031
Figure 25: Global Taurine Market, by Form
Figure 26: Global Taurine Market Value Share and Attractiveness Analysis, by Form, 2020 and 2031
Figure 27: Global Taurine Market Value Share and Attractiveness Analysis, by Form, 2021–2031
Figure 28: Global Taurine Market Revenue (US$ Mn), by Tablets/Capsules, 2017–2031
Figure 29: Global Taurine Market Revenue (US$ Mn), by Liquid-based Serum, 2017–2031
Figure 30: Global Taurine Market Value (US$ Mn), by Others, 2017–2031
Figure 31: Global Taurine Market Value Share Analysis, by Region, 2020 and 2031
Figure 32: Global Taurine Market Analysis, by Region
Figure 33: North America Taurine Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 34: North America Taurine Market Analysis Value Share Analysis, by Country, 2020 and 2031
Figure 35: North America Taurine Market Analysis Attractiveness Analysis, by Country 2021–2031
Figure 36: North America Taurine Market Value Share Analysis, by Type, 2020 and 2031
Figure 37: North America Taurine Market Attractiveness Analysis, by Type, 2021–2031
Figure 38: North America Taurine Market Value Share and Attractiveness Analysis, by Application, 2020 and 2031
Figure 39: North America Taurine Market Value Share and Attractiveness Analysis, by Application, 2021–2031
Figure 40: North America Taurine Market Value Share and Attractiveness Analysis, by Form, 2020 and 2031
Figure 41: North America Taurine Market Value Share and Attractiveness Analysis, by Form, 2021–2031
Figure 42: Europe Taurine Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 43: Europe Taurine Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 44: Europe Taurine Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 45: Europe Taurine Market Value Share Analysis, by Type, 2020 and 2031
Figure 46: Europe Taurine Market Attractiveness Analysis, by Type, 2021–2031
Figure 47: Europe Taurine Market Value Share and Attractiveness Analysis, by Application, 2020 and 2031
Figure 48: Europe Taurine Market Value Share and Attractiveness Analysis, by Application, 2021–2031
Figure 49: Europe Taurine Market Value Share and Attractiveness Analysis, by Form, 2020 and 2031
Figure 50: Europe Taurine Market Value Share and Attractiveness Analysis, by Form, 2021–2031
Figure 51: Asia Pacific Taurine Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 52: Asia Pacific Taurine Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 53: Asia Pacific Taurine Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 54: Asia Pacific Taurine Market Value Share Analysis, by Type, 2020 and 2031
Figure 55: Asia Pacific Taurine Market Attractiveness Analysis, by Type, 2021–2031
Figure 56: Asia Pacific Taurine Market Value Share and Attractiveness Analysis, by Application, 2020 and 2031
Figure 57: Asia Pacific Taurine Market Value Share and Attractiveness Analysis, by Application, 2021–2031
Figure 58: Asia Pacific Taurine Market Value Share and Attractiveness Analysis, by Form, 2020 and 2031
Figure 59: Asia Pacific Taurine Market Value Share and Attractiveness Analysis, by Form, 2021–2031
Figure 60: Latin America Taurine Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 61: Latin America Taurine Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 62: Latin America Taurine Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 63: Latin America Taurine Market Value Share Analysis, by Type, 2020 and 2031
Figure 64: Latin America Taurine Market Attractiveness Analysis, by Type, 2021–2031
Figure 65: Latin America Taurine Market Value Share and Attractiveness Analysis, by Application, 2020 and 2031
Figure 66: Latin America Taurine Market Value Share and Attractiveness Analysis, by Application, 2021–2031
Figure 67: Latin America Taurine Market Value Share and Attractiveness Analysis, by Form, 2020 and 2031
Figure 68: Latin America Taurine Market Value Share and Attractiveness Analysis, by Form, 2021–2031
Figure 69: Middle East & Africa Taurine Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 70: Middle East & Africa Taurine Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 71: Middle East & Africa Taurine Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 72: Middle East & Africa Taurine Market Value Share Analysis, by Type, 2020 and 2031
Figure 73: Middle East & Africa Taurine Market Attractiveness Analysis, by Type, 2021–2031
Figure 74: Middle East & Africa Taurine Market Value Share and Attractiveness Analysis, by Application, 2020 and 2031
Figure 75: Middle East & Africa Taurine Market Value Share and Attractiveness Analysis, by Application, 2021–2031
Figure 76: Middle East & Africa Taurine Market Value Share and Attractiveness Analysis, by Form, 2020 and 2031
Figure 77: Middle East & Africa Taurine Market Value Share and Attractiveness Analysis, by Form, 2021–2031
Figure 78: Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020
Figure 79: Breakdown of Net Sales (%), by Geography, 2020
Figure 80: Breakdown of Net Sales (%), by Product Category, 2020
Figure 81: Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020
Figure 82: Breakdown of Net Sales (%), by Segment, 2020
Figure 83: Breakdown of Net Sales (%), by Geography, 2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Taurine Market
